State-Licensed Marijuana Operators Face Long DEA Registration Waits

What the Rutland Herald Reported

The Rutland Herald reported Oct. 17 that state-licensed marijuana businesses should expect long delays in obtaining DEA federal registrations.

CannIntel worked from the report's headline and summary. Processing timelines, application counts and named agency officials that the full story may contain were not available to us, and this article doesn't supply figures the signal didn't.

What the headline does establish is the direction of the concern. The bottleneck isn't the policy decision. It's the paperwork.

Why Registration Is the Choke Point

Federal law requires anyone who manufactures, distributes or dispenses a controlled substance to register with the DEA.

That requirement sits in 21 U.S.C. 822, with the standards for granting registrations set out in section 823. Marijuana is currently a Schedule I substance. State-licensed cultivators, processors and dispensaries have never held DEA registrations for it, and federal registration for Schedule I has largely been confined to research.

If marijuana moved to Schedule III, the registration framework that governs other controlled substances would become the natural compliance route. A slow DEA queue would then decide how quickly operators could get there.

The Rescheduling Backdrop

The Justice Department proposed moving marijuana to Schedule III in a notice of proposed rulemaking published May 21, 2024.

You'll find the proposal at 89 Fed. Reg. 44597. It drew requests for a formal administrative hearing before a DEA administrative law judge, which pulled the rulemaking into a contested process rather than a quick final rule.

As of Oct. 17, the signal didn't describe where that rulemaking stands, and we haven't assumed an outcome. The latest status is tracked on the CannIntel topic hub on DEA rescheduling.

What a Backlog Would Mean for Operators

A registration backlog would create a gap between a change in federal schedule and an operator's ability to comply with it.

That gap is the practical risk, and it's our read of the headline rather than a finding from the report. Reclassification alone wouldn't dissolve the conflict between state licenses and federal law, because the Controlled Substances Act's registration and recordkeeping obligations would still apply to each business. Operators waiting on the DEA would be in a legal holding pattern, with the same exposure they carry today but a new compliance standard they can't yet meet.

Not a comfortable place to be.

The 280E Question

The tax relief operators want from Schedule III is tied to Section 280E of the Internal Revenue Code, and registration timing could complicate it.

Section 280E bars deductions and credits for businesses trafficking in Schedule I or II substances, which is why cannabis companies carry effective tax rates far above other industries. Removing marijuana from those schedules is the mechanism that would end the penalty. Whether the IRS would treat a business awaiting registration the same as a registered one is a question tax counsel will press, and the signal didn't answer it.

Operators shouldn't build 2027 budgets around savings they can't yet document. That's a prudent read, not a forecast.

Who Feels It First

Smaller single-state operators would likely absorb the cost of a slow queue more heavily than multistate operators with in-house compliance teams.

MSOs can staff application work, retain Washington counsel and carry the cost of waiting. A single-location dispensary in California or a small Ohio cultivator can't do the same without pulling resources from operations. The report's headline suggests the wait itself is the story. Delays tend to favor companies with the deepest balance sheets.

State regulators, including California's Department of Cannabis Control and Ohio's Division of Cannabis Control, haven't been named in the signal as parties to the issue. They would still field operator questions about how federal registration squares with state licenses.

What to Watch Next

The next measurable signal is whether the DEA publishes processing targets or a dedicated application pathway for state-licensed marijuana businesses.

Without a published timeline, the Rutland Herald's reporting stays a warning rather than a metric. Watch for DEA Diversion Control Division guidance and any Federal Register notice on registration procedures. Then there's the final status of the Schedule III rulemaking.